Legend Biotech earnings release, September 24, 2026
Voting Results of 2026 Annual General Meeting
At Legend Biotech Corporation’s (the “Company”) annual general meeting of shareholders held on September 24, 2026 (the “AGM”), the Company’s shareholders:
A total of approximately 330,199,682 ordinary shares, including those underlying ADSs, representing approximately 84.9% of the 388,976,826 ordinary shares issued and outstanding as of August 17, 2026, the record date, were present in person or by proxy at the AGM. The results of the votes are as follows: